Recruiting NA Hemolysis

New treatment option for Hemolysis

Official title Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis

ClinicalTrials.gov ID: NCT06806891

What this study is testing

What it's testing
the restless leg syndrome is a common complaint in person who undergo hemodialysis. Buddhist walking meditation efficacy was not investigated in those population

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 35 to 65

You may be able to join if

  • hemodialysis patient (40)
  • complain of restless leg syndrome
  • non obese patients

You likely can't join if

  • cardiac patients
  • chest diseases
  • mental diseases
  • hepatic diseases
  • lower limb orthopedic hurting

The study team makes the final eligibility decision.

Where it's taking place

  • Dokki, Giza Governorate, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 35 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Dokki, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.